TITLE

Adrenocortical carcinoma: a diagnostic and treatment dilemma

AUTHOR(S)
Khan, Sheraz; Imtiaz, Komal E.
PUB. DATE
January 2009
SOURCE
British Journal of Hospital Medicine (17508460);Jan2009, Vol. 70 Issue 1, p46
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on the treatment and diagnosis of adrenocortical carcinoma in Great Britain. Eventhough laparoscopic adrenalectomy is a proven standard for treating adrenal tumors, it is not indicated for a tumour of any size when invasion of surrounding tissues are clearly detected by preoperative imaging. When researchers evaluate the efficacy of laparoscopic adrenalectomy, they found that it should not be performed if there is any possibility of adrenocortical malignancy.
ACCESSION #
36157001

 

Related Articles

  • Cisto hemorrágico da glândula adrenal. da Silva, Elsa Cristina Fontes Pires; Viamontez, Francisco; Silva, Vasco Sabino; Andrade, Artur; Neto, Gonçalo Júlio; de Palma Gomes, Constança; Neto, Sérgio; Quitembo, Mateus; Dimbany, Higino; Van-Dunem, Joaquim Carlos Vicente Dias; de Miranda, Sandra Maria da Rocha Neto; Bastos, Fernando; Cordeiro, Lemuel Bornelli; Guilherme, Mateus // Einstein (16794508);Jan-Mar2012, Vol. 10 Issue 1, p96 

    The authors present a case of a hemorrhagic adrenal cyst, one of the tumors known in literature as incidentalomas, emphasizing the clinical characteristics, since adrenal cysts or pseudocysts are generally rare and observed by chance during imaging procedures. Traditionally they are classified...

  • Presacral tumours in adults. Ghost, J.; Eglinton, T.; Frizelle, F. A.; Watson, A. J. M. // Surgeon (Edinburgh University Press);Feb2007, Vol. 5 Issue 1, p31 

    Presacral tumours represent a heterogeneous group of predominantly benign and occasionally malignant neoplasms. Due to the rarity of these tumours, their management is often performed in an ad hoc fashion and an algorithm for optimal treatment remains undefined. This review aims to present an...

  • Prognostic relevance of p53 and bcl-2 immunoreactivity for early invasive pT1/pT2 gastric carcinomas: indicators for limited gastric resections? Kopp, R.; Diebold, J.; Dreier, I.; Cramer, C.; Glas, J.; Baretton, G.; Jauch, K. W. // Surgical Endoscopy;Nov2005, Vol. 19 Issue 11, p1507 

    Background: Laparoscopic or endoscopic limited resection is intended to be an additional therapeutic option for the treatment of early gastric cancer. However, tumorbiologic markers to predict the outcome for patients after limited resections are missing. This study therefore...

  • Clinical: Cervical cancer, part two.  // GP: General Practitioner;11/25/2005, p65 

    The article presents information on the features of cervical intraepithelial neoplasia (CIN). The potential of CIN to progress is unknown. Cytological abnormalities are termed dyskaryosis, while histological abnormalities are classified as CIN. There is a great deal of controversy about the...

  • Myth: Exposing a tumor to air during surgery causes cancer to spread.  // Mayo Clinic Guide to Women's Cancers;2005, p349 

    This article clarifies the misconception regarding the spreading of cancer by exposing a tumor to air during surgery. Because you may feel worse during your recovery than you did before surgery, you might believe the surgery caused your cancer to spread. However, air hitting the tumor does not...

  • Harnessing the potential of epigenetic therapy to target solid tumors. Ahuja, Nita; Easwaran, Hariharan; Baylin, Stephen B. // Journal of Clinical Investigation;Jan2014, Vol. 124 Issue 1, p56 

    Epigenetic therapies may play a prominent role in the future management of solid tumors. This possibility is based on the clinical efficacy of existing drugs in treating defined hematopoietic neoplasms, paired with promising new data from preclinical and clinical studies that examined these...

  • Elucidation of the tumoritropic principle of hypericin. Van de Putte, M.; Roskams, T.; Vandenheede, J. R.; Agostinis, P.; de Witte, P. A. M. // British Journal of Cancer;4/25/2005, Vol. 92 Issue 8, p1406 

    Hypericin is a potent agent in the photodynamic therapy of cancers. To better understand its tumoritropic behaviour, we evaluated the major determinants of the accumulation and dispersion of hypericin in subcutaneously growing mouse tumours. A rapid exponential decay in tumour accumulation of...

  • The functional and structural characterization of a novel oncogene GIG47 involved in the breast tumorigenesis. Kyou-Hoon Han; Si-Hyung Lee; Seon-Ah Ha; Hyun Kee Kim; CheWook Lee; Do-Hyoung Kim; Kee Hwan Gong; JinAh Yoo; Sanghee Kim; Jin Woo Kim // BMC Cancer;2012, Vol. 12 Issue 1, p274 

    Background: A candidate oncogene GIG47, previously known as a neudesin with a neurotrophic activity, was identified by applying the differential expression analysis method. Methods: As a first step to understand the molecular role of GIG47, we analyzed the expression profile of GIG47 in multiple...

  • Sometimes Size Doesn't Matter: Reevaluating RECIST and Tumor Response Rate Endpoints. Tuma, Rabiya S. // JNCI: Journal of the National Cancer Institute;9/20/2006, Vol. 98 Issue 18, p1272 

    The article discusses the reevaluation of Response Evaluation Criteria in Solid Tumors (RECIST) and tumor response rate in the U.S. Intricately, RECIST has been called into question because of two developments in medicine, which include the improvements in the imaging techniques that allow...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics